These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33461144)

  • 1. Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors.
    Curreli F; Ahmed S; Benedict Victor SM; Iusupov IR; Spiridonov EA; Belov DS; Altieri A; Kurkin AV; Debnath AK
    Bioorg Med Chem; 2021 Feb; 32():116000. PubMed ID: 33461144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and evaluation of small molecule CD4-mimics as entry inhibitors possessing broad spectrum anti-HIV-1 activity.
    Curreli F; Belov DS; Ramesh RR; Patel N; Altieri A; Kurkin AV; Debnath AK
    Bioorg Med Chem; 2016 Nov; 24(22):5988-6003. PubMed ID: 27707628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120.
    Curreli F; Belov DS; Kwon YD; Ramesh R; Furimsky AM; O'Loughlin K; Byrge PC; Iyer LV; Mirsalis JC; Kurkin AV; Altieri A; Debnath AK
    Eur J Med Chem; 2018 Jun; 154():367-391. PubMed ID: 29860061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors.
    Tsuji K; Kobayakawa T; Konno K; Masuda A; Takahashi K; Ohashi N; Yoshimura K; Kuwata T; Matsushita S; Harada S; Tamamura H
    Bioorg Med Chem; 2022 Feb; 56():116616. PubMed ID: 35063895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral Activity and Crystal Structures of HIV-1 gp120 Antagonists.
    Curreli F; Kwon YD; Nicolau I; Burgos G; Altieri A; Kurkin AV; Verardi R; Kwong PD; Debnath AK
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.
    Courter JR; Madani N; Sodroski J; Schön A; Freire E; Kwong PD; Hendrickson WA; Chaiken IM; LaLonde JM; Smith AB
    Acc Chem Res; 2014 Apr; 47(4):1228-37. PubMed ID: 24502450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
    Curreli F; Kwon YD; Belov DS; Ramesh RR; Kurkin AV; Altieri A; Kwong PD; Debnath AK
    J Med Chem; 2017 Apr; 60(7):3124-3153. PubMed ID: 28266845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Antiviral activity of 1,2,3,4-Tetrahydropyrimidine derivatives acting as novel entry inhibitors to target at "Phe43 cavity" of HIV-1 gp120.
    Senapathi J; Bommakanti A; Kusuma V; Vangara S; Kondapi AK
    Bioorg Med Chem; 2021 Dec; 52():116526. PubMed ID: 34839157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Antiviral Activity of the Thiazole Positional Isomers of a Potent HIV-1 Entry Inhibitor NBD-14270.
    Kurkin AV; Curreli F; Iusupov IR; Spiridonov EA; Ahmed S; Markov PO; Manasova EV; Altieri A; Debnath AK
    ChemMedChem; 2022 Nov; 17(22):e202200344. PubMed ID: 36097139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Aminothiazolones as anti-HIV agents that act as gp120-CD4 inhibitors.
    Tiberi M; Tintori C; Ceresola ER; Fazi R; Zamperini C; Calandro P; Franchi L; Selvaraj M; Botta L; Sampaolo M; Saita D; Ferrarese R; Clementi M; Canducci F; Botta M
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3043-52. PubMed ID: 24614386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Based Design of a Small Molecule CD4-Antagonist with Broad Spectrum Anti-HIV-1 Activity.
    Curreli F; Kwon YD; Zhang H; Scacalossi D; Belov DS; Tikhonov AA; Andreev IA; Altieri A; Kurkin AV; Kwong PD; Debnath AK
    J Med Chem; 2015 Sep; 58(17):6909-6927. PubMed ID: 26301736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding mode characterization of NBD series CD4-mimetic HIV-1 entry inhibitors by X-ray structure and resistance study.
    Curreli F; Kwon YD; Zhang H; Yang Y; Scacalossi D; Kwong PD; Debnath AK
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5478-91. PubMed ID: 25001301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors.
    Ohashi N; Harada S; Mizuguchi T; Irahara Y; Yamada Y; Kotani M; Nomura W; Matsushita S; Yoshimura K; Tamamura H
    ChemMedChem; 2016 Apr; 11(8):940-6. PubMed ID: 26891461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.
    Lu L; Yu F; Cai L; Debnath AK; Jiang S
    Curr Top Med Chem; 2016; 16(10):1074-90. PubMed ID: 26324044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble-type small-molecule CD4 mimics as HIV entry inhibitors.
    Kobayakawa T; Konno K; Ohashi N; Takahashi K; Masuda A; Yoshimura K; Harada S; Tamamura H
    Bioorg Med Chem Lett; 2019 Mar; 29(5):719-723. PubMed ID: 30665681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates.
    Matsumoto K; Kuwata T; Tolbert WD; Richard J; Ding S; Prévost J; Takahama S; Judicate GP; Ueno T; Nakata H; Kobayakawa T; Tsuji K; Tamamura H; Smith AB; Pazgier M; Finzi A; Matsushita S
    J Virol; 2023 Jan; 97(1):e0163822. PubMed ID: 36511698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Discovery and Development of Oxalamide and Pyrrole Small Molecule Inhibitors of gp120 and HIV Entry - A Review.
    Motati DR; Uredi D; Watkins EB
    Curr Top Med Chem; 2019; 19(18):1650-1675. PubMed ID: 31424369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitors.
    LaLonde JM; Kwon YD; Jones DM; Sun AW; Courter JR; Soeta T; Kobayashi T; Princiotto AM; Wu X; Schön A; Freire E; Kwong PD; Mascola JR; Sodroski J; Madani N; Smith AB
    J Med Chem; 2012 May; 55(9):4382-96. PubMed ID: 22497421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Progress in the Development of HIV-1 Entry Inhibitors: From Small Molecules to Potent Anti-HIV Agents.
    Suttisintong K; Kaewchangwat N; Thanayupong E; Nerungsi C; Srikun O; Pungpo P
    Curr Top Med Chem; 2019; 19(18):1599-1620. PubMed ID: 31424370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.